KONINKLIJKE PHILIPS NV
For the period ended Oct 31, 2026. Filed Nov 3, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Oct 31, 2026 · Filed Nov 3, 2026
Use the contents to explore the available documents and sections.
Contents
Outlook
Philips reiterates its full-year 2026 outlook:
Comparable sales growth: 3%-4.5%
Adjusted EBITA margin: 13.5%-14.0%, including a US tariff refund benefit of approximately 1%
Free cash flow: EUR 1.5-1.7 billion, including a net US tariff refund benefit of approximately EUR 200 million
Within the context of an uncertain macro-environment, Philips' 2026 outlook includes currently known tariffs and assumes payment of the US Department of Justice settlement in the first quarter of 2027. The outlook excludes other ongoing Philips Respironics-related proceedings, including the investigation by the US State Attorneys General.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.